2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
22
Prostatic Neoplasms
11
Osteoporosis
8
Vitamin D Deficiency
7
Polycystic Ovary Syndrome
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Colonic Neoplasms
5
Neoplasms
4
Obesity
3
Neoplasm Metastasis
3
Lung Neoplasms
3
Inflammation
3
Colorectal Neoplasms
3
Carcinoma, Hepatocellular
3
Bone Diseases, Metabolic
3
Multiple Endocrine Neoplasia Type 1
2
Motor Activity
2
Lymphoma
2
Leukemia
2
Leiomyoma
2
Giant Cell Tumor of Bone
2
Gastrointestinal Neoplasms
2
Cardiovascular Diseases
2
Carcinoma, Transitional Cell
2
Brain Neoplasms
2
Bone Diseases
2
Warts
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Interventions
tofacitinib
7
Etanercept
7
Methotrexate
4
Adalimumab
4
deucravacitinib
3
secukinumab
2
apremilast
2
Nivolumab
2
sotrastaurin
1
sodium luminolate
1
purine
1
ixekizumab
1
fumaric acid
1
calcipotriene
1
cabozantinib
1
baricitinib
1
abrocitinib
1
Vitamin D
1
Vaccines
1
Sulfasalazine
1
Standard of Care
1
Specimen Handling
1
Saline Solution
1
Practice Guidelines as Topic
1
Platinum Compounds
1
Methods
1
Mesalamine
1
Mercaptopurine
1
Ipilimumab
1
Interviews as Topic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Psoriasis
×
Vitamin D
×
Clear all
NCT01351805
2025-12-03
VITAL
Brigham and Women's Hospital
Phase NA
Completed
25,871 enrolled
15 charts